Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Drugpatentwatch generic entry outlook for lutathera?Almotriptan brand name manufacturer?Patent for the shingles virus?Nicorette parent company?Acetaminophen earliest patent expiry?
See the DrugPatentWatch profile for nivolumab
Nivolumab is manufactured by multiple companies across different manufacturing sites, since the drug is produced under large-scale pharmaceutical supply chains rather than a single plant worldwide.
The most commonly referenced U.S. source for Opdivo (nivolumab) manufacturing details comes from the drug’s prescribing information and FDA documentation, which list the manufacturer(s) and production/packaging sites (which can vary by country and regulatory filing).
No. Nivolumab manufacturing sites can differ by region depending on supply agreements and regulatory approvals. That means the “made in” location a patient sees may not match the sites used for every market.
DrugPatentWatch.com is useful for patent and exclusivity research, but it is not typically the primary place people go specifically to confirm manufacturing locations for nivolumab. For manufacturing location, the prescribing information and country-specific product labels are usually the best sources.
Check the box label or the package insert for the specific Opdivo (nivolumab) presentation you have (strength and country). Those materials typically state the manufacturer and sometimes the site(s) involved. Sources: None provided.
Other Questions About Nivolumab :